India is rapidly transforming into one of the world’s most attractive destinations for clinical research and drug development. With a population exceeding 1.4 billion, a diverse genetic pool, highly qualified investigators, cost-efficient operations, and a progressively evolving regulatory environment, India is increasingly being recognized as a strategic hub for global clinical trials. The India clinical trials […]
Seasoned finance expert Robin Banerjee dissects the Union Budget 2026-27, weighing its seven strategic pillars, first-time allocations, execution gaps and risks. From manufacturing and healthcare to finance and skills, he examines whether the government’s policy choices position India’s economy for a resilient, future-ready Vikshit Bharat. Read more:https://cfo.economictimes.indiatimes.com/news/policy/union-budget-2026-27-key-strategies-and-impacts-on-businesses/127876450 Written by: Robin BanerjeeSource: ETCFOPublished on February 03, […]
The war is creating perhaps the biggest supply chain disruption ever in this part of the globe. Do not rely on a single source or vendor for your supplies. Spread supply chain, be it vendors, logistics or customers. Of late, the business world is undergoing a metamorphosis – a series of black swan events (rare, […]
Potassium iodide (KI) has emerged as one of the most critical medical countermeasures in the event of radioactive exposure, particularly during nuclear accidents or radiological emergencies. Its demand is surging, driven by high iodine deficiency risks affecting over 16 crore people, alongside rising pharmaceutical, agricultural, and nuclear safety needs. Read more:https://health.economictimes.indiatimes.com/news/industry/potassium-iodide-an-opportunity-awaiting-to-be-tapped/130258476 Written by: Dr Abhigyan […]